Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - ivermectin; praziquantel - oral paste - ivermectin anthelmintic active 18.7 mg/g; praziquantel anthelmintic active 140.0 mg/g - parasiticides - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - ascarid - parasacris equorium | bots - gasterophilus spp. | cutaneous onchocerciasis | intestinal threadworm - s. westeri | large mouth stomach worm | large strongyles | lungworm - dictyocaulus arnfieldi | neck threadworm | pinworm - oxyuris equi | small strongyles | stomach hair worm | summer sores | tapeworm - adult/immature/heads/segments | anoplocephala magna | anoplocephala perfoliata | bot fly | bot fly - oral and gastric sta | coronocyclus spp. | craterostomum acuticaudatum | cutaneous larvae | cutaneous onchocerciasis | cyalocephalus spp. | cyathostomum spp. | cylicocyclus spp. | cylicodontophorus spp. | cylicostephanus spp. | cyliocostephanus spp. | cyliocyclus spp. | gasterophilus haemorrhoidalis | gasterophilus inermis | gasterophilus intestinalis | gasterophilus nasalis | gasterophilus pecorum | gyalocephalus spp. | paranoplocephala mammillana | parapoteriostomum spp. | petrovinema spp. | poteriostomum spp. | stomach bot | strongylus edentatus | strongylus equinus | strongylus vulgaris | summer so

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - clenbuterol hydrochloride; trimethoprim; sulfadiazine - oral powder, pre-mix - clenbuterol hydrochloride anilide/aniline active 21.44 ug/g; trimethoprim pyrimidine active 67.0 mg/g; sulfadiazine sulfanyl active 335.0 mg/g - respiratory + antibiotic - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - bronchodilator | respiratory disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - pentosan polysulfate sodium - parenteral liquid/solution/suspension - pentosan polysulfate sodium mineral-sodium active 100.0 mg/ml - musculoskeletal system - dog | bitch | castrate | puppy - inflammatory joint disease | non-infectious joint disease

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base - solution for injection - 0.05 mg/ml - active: octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 11.2mg equivalent to octreotide 10 mg;   - powder for injection - 10 mg - active: octreotide acetate 11.2mg equivalent to octreotide 10 mg   excipient: mannitol polyglactin carmellose sodium mannitol poloxamer water for injection carmellose sodium mannitol water for injection - treatment of patients with acromegaly: · in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours: · carcinoid tumours with features of the carcinoid syndrome. · vipomas · glucagonomas · gastrinomas/zollinger-ellison syndrome · insulinomas, for pre-operative control of hypoglycaemia and for maintenance therapy. · grfomas

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 22.4mg equivalent to octreotide 20 mg;   - powder for injection - 20 mg - active: octreotide acetate 22.4mg equivalent to octreotide 20 mg   excipient: mannitol polyglactin carmellose sodium mannitol poloxamer water for injection carmellose sodium mannitol water for injection - treatment of patients with acromegaly: · in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours: · carcinoid tumours with features of the carcinoid syndrome. · vipomas · glucagonomas · gastrinomas/zollinger-ellison syndrome · insulinomas, for pre-operative control of hypoglycaemia and for maintenance therapy. · grfomas

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 33.6mg equivalent to octreotide 30 mg;   - powder for injection - 30 mg - active: octreotide acetate 33.6mg equivalent to octreotide 30 mg   excipient: mannitol polyglactin carmellose sodium mannitol poloxamer water for injection carmellose sodium mannitol water for injection - treatment of patients with acromegaly: · in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours: · carcinoid tumours with features of the carcinoid syndrome. · vipomas · glucagonomas · gastrinomas/zollinger-ellison syndrome · insulinomas, for pre-operative control of hypoglycaemia and for maintenance therapy. · grfomas

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - ambroxol hydrochloride - tablet - 30 mg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - meloxicam - parenteral liquid/solution/suspension - meloxicam ungrouped active 20.0 mg/ml - musculoskeletal system

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - omeprazole - oral paste - omeprazole imidazole active 370.0 mg/g - alimentary system